Expanded Neonatal Bloodspot Screening Programmes: An Evaluation Framework to Discuss New Conditions With Stakeholders

by Marleen E. Jansen, Marleen E. Jansen, Anne W. Klein, Erika C. Buitenhuis, Wendy Rodenburg, Martina C. Cornel
Published 2021-02-01

Implementation of Pharmacogenetics in Primary Care: A Multi-Stakeholder Perspective

by Tessel Rigter, Tessel Rigter, Marleen E. Jansen, Marleen E. Jansen, Jordy M. de Groot, Susan W.J. Janssen, Wendy Rodenburg, Martina C. Cornel
Published 2020-01-01

Review of the Reported Measures of Clinical Validity and Clinical Utility as Arguments for the Implementation of Pharmacogenetic Testing: A Case Study of Statin-Induced Muscle Toxi...

by Marleen E. Jansen, Marleen E. Jansen, T. Rigter, T. Rigter, W. Rodenburg, T. M. C. Fleur, T. M. C. Fleur, E. J. F. Houwink, M. Weda, Martina C. Cornel
Published 2017-08-01

Informing Parents about Newborn Screening: A European Comparison Study

by Amber IJzebrink, Tessa van Dijk, Věra Franková, J. Gerard Loeber, Viktor Kožich, Lidewij Henneman, Marleen E. Jansen
Published 2021-02-01

Parental perspectives on retention and secondary use of neonatal dried bloodspots: a Dutch mixed methods study

by Marleen E. Jansen, Lion J. M. van den Bosch, Marjolein J. Hendriks, Mariska M. J. Scheffer, Marie-Louise Heijnen, Conor M. W. Douglas, Carla G. van El
Published 2019-07-01